Olema Pharmaceuticals Inc (NASDAQ: OLMA) kicked off on Tuesday, down -5.86% from the previous trading day, before settling in for the closing price of $8.7. Over the past 52 weeks, OLMA has traded in a range of $2.86-$13.06.
Annual sales at Healthcare sector company slipped by -83.00% over the past five years. While this was happening, its average annual earnings per share was recorded 12.10%. With a float of $52.86 million, this company’s outstanding shares have now reached $68.65 million.
Olema Pharmaceuticals Inc (OLMA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 22.99%, while institutional ownership is 85.87%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.51 earnings per share (EPS), lower than consensus estimate (set at 0.17) by -0.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.31% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Take a look at Olema Pharmaceuticals Inc’s (OLMA) current performance indicators. Last quarter, stock had a quick ratio of 8.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.27 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Olema Pharmaceuticals Inc (NASDAQ: OLMA) saw its 5-day average volume 0.83 million, a negative change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 36.70%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 55.42%, which indicates a significant increase from 24.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.59 in the past 14 days, which was higher than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.84, while its 200-day Moving Average is $5.77. Nevertheless, the first resistance level for the watch stands at $8.59 in the near term. At $8.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.33. If the price goes on to break the first support level at $7.85, it is likely to go to the next support level at $7.50. The third support level lies at $7.11 if the price breaches the second support level.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
The company with the Market Capitalisation of 597.34 million has total of 68,634K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -129,470 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -43,780 K.
